APOBEC Mutational Signatures in Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative Breast Cancers Are Associated With Poor Outcomes on CDK4/6 Inhibitors and Endocrine Therapy.

导出 LinkOut

翻译打印收藏纠错

作者： Sarah,Sammons ^[1] ; Kira,Raskina ^[2] ; Natalie,Danziger ^[2] ; Laura,Alder ^[1] ; Alexa B,Schrock ^[2] ; Jeffrey M,Venstrom ^[2] ; Keith L,Knutson ^[3] ; E Aubrey,Thompson ^[4] ; Kim,McGregor ^[2] ; Ethan,Sokol ^[2] ; Saranya,Chumsri ^[5]

作者单位： Duke Cancer Institute, Duke University, Durham, NC.;Department of Medicine, Division of Medical Oncology, Duke University, Durham, NC. ^[1] Foundation Medicine, Inc, Cambridge, MA. ^[2] Department of Immunology, Mayo Clinic, Jacksonville, FL. ^[3] Department of Cancer Biology, Mayo Clinic, Jacksonville, FL. ^[4] Department of Cancer Biology, Mayo Clinic, Jacksonville, FL.;Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL. ^[5]

主题词人类(Humans);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);细胞周期蛋白依赖激酶4(Cyclin-Dependent Kinase 4);受体, 雌激素(Receptors, Estrogen);美国(United States);细胞周期蛋白依赖激酶6(Cyclin-Dependent Kinase 6);乳腺肿瘤(Breast Neoplasms)

DOI 10.1200/PO.22.00149

PMID 36315915

发布时间 2024-09-07

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

JCO precision oncology

2022年6卷

e2200149页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

APOBEC Mutational Signatures in Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative Breast Cancers Are Associated With Poor Outcomes on CDK4/6 Inhibitors and Endocrine Therapy.

JCO precision oncology

相似文献

JCO precision oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

APOBEC Mutational Signatures in Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative Breast Cancers Are Associated With Poor Outcomes on CDK4/6 Inhibitors and Endocrine Therapy.

JCO precision oncology

相似文献

JCO precision oncology

相关期刊

检索历史清除